Erin M Kelly

Summary

Country: Canada

Publications

  1. doi Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment
    Erin M Kelly
    Department of Medicine, The Ottawa Hospital, Division of Infectious Diseases, Viral Hepatitis Program, University of Ottawa, Ottawa, Canada
    Eur J Gastroenterol Hepatol 24:811-6. 2012
  2. doi Hepatitis C antiviral treatment outcomes are comparable between clinical trial participants and recipients of standard-of-care therapy: an analysis of trial effect
    Erin M Kelly
    Department of Medicine, Division of Gastroenterology, University of Ottawa, Ottawa, Canada
    Eur J Gastroenterol Hepatol 25:1177-82. 2013

Detail Information

Publications2

  1. doi Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment
    Erin M Kelly
    Department of Medicine, The Ottawa Hospital, Division of Infectious Diseases, Viral Hepatitis Program, University of Ottawa, Ottawa, Canada
    Eur J Gastroenterol Hepatol 24:811-6. 2012
    ..As this risk has not been well quantified in bipolar patients, we evaluated the safety and efficacy of HCV treatment in this population...
  2. doi Hepatitis C antiviral treatment outcomes are comparable between clinical trial participants and recipients of standard-of-care therapy: an analysis of trial effect
    Erin M Kelly
    Department of Medicine, Division of Gastroenterology, University of Ottawa, Ottawa, Canada
    Eur J Gastroenterol Hepatol 25:1177-82. 2013
    ..Trial effect refers to the impact of clinical trial participation on treatment outcomes. Little literature exists evaluating the magnitude and direction of trial effect in hepatitis C virus (HCV)...